Filing Flows › Si-Bone (SIBN) › Q3 2026 › vs Q2 2026
Si-Bone (SIBN) Q3 2026 vs Q2 2026 (quarter over quarter)
Si-Bone's revenue fell $306K (-0.5%) from $56.0M in Q2 2026 to $55.7M in Q3 2026.
Si-Bone, Q3 2026: revenue $55.7M (+14% year over year), operating margin -7.8%, net loss $3.6M, operating cash flow $5.9M. The chart draws each line against Q2 2026, the increases inside each band.
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $55.7M | $56.0M | −$306K | -0.5% |
| Other income, net | $731K | $718K | $13K | +2% |
| Net loss | $3.6M | $4.1M | −$468K | -11% |
| Costs & expenses | $60.1M | $60.8M | −$761K | -1% |
| Operating costs | $60.1M | $60.8M | −$761K | -1% |
| Cost of revenue | $11.5M | $11.5M | $75K | +0.7% |
| Research & development | $4.6M | $5.2M | −$659K | -13% |
| Sales & marketing | $33.9M | $34.0M | −$174K | -0.5% |
| General & admin | $10.1M | $10.1M | −$3K | 0% |
| Operating cash sources | $9.6M | $4.9M | $4.7M | +97% |
| Depreciation & amortization | $1.7M | $1.7M | $15K | +0.9% |
| Share-based compensation | $5.7M | $6.0M | −$266K | -4% |
| Working capital & other | $2.2M | −$2.8M | $4.9M | — |
| Net loss absorbed | $3.6M | $4.1M | −$468K | -11% |
| Operating cash flow | $5.9M | $777K | $5.2M | +664% |
| Capital expenditures | $6.4M | $1.5M | $4.8M | +312% |
| Negative free cash flow (OCF − capex) | $427K | $768K | −$341K | -44% |
Questions
How much did Si-Bone's revenue grow quarter over quarter in Q3 2026?
Si-Bone's revenue fell $306K (-0.5%) from $56.0M in Q2 2026 to $55.7M in Q3 2026.